The pathogenesis of xanthomata.
D000818:Animals; D001011:Aorta / Q000473:pathology; D001796:Blood Protein Disorders / Q000150:complications*; D001920:Bradykinin / Q000008:administration & dosage; D002199:Capillary Permeability; D002784:Cholesterol; D003238:Connective Tissue / Q000378:metabolism; D004041:Dietary Fats; D005260:Female; D005455:Fluorescent Antibody Technique; D006632:Histamine / Q000008:administration & dosage; D006644:Histiocytes / Q000378:metabolism; D007279:Injections, Subcutaneous; D008074:Lipoproteins / Q000097:blood* / Q000378:metabolism; D008297:Male; D010587:Phagocytosis; D011727:Pyridinolcarbamate / Q000494:pharmacology; D011817:Rabbits; D012867:Skin / Q000293:injuries; D014973:Xanthomatosis / Q000201:enzymology / Q000209:etiology* / Q000276:immunology / Q000473:pathology
D004041:Dietary Fats; D008074:Lipoproteins; D011727:Pyridinolcarbamate; D006632:Histamine; D002784:Cholesterol; D001920:Bradykinin